Skip to Main Content

Most physicians who endorsed a prescription drug or medical device on X — formerly known as Twitter — also received payments from the manufacturers of these products, according to a new analysis that highlights ongoing concerns about financial ties between doctors and industry.

The study found 26 of 28 physicians, or 93%, received at least one payment, and the average was more than $27,400 for such things as food and beverages, speaking, consulting, or travel. In 24 instances, the payments were related to a specific medicine or device that was endorsed on the social media platform. Only one physician was paid for research — nearly $225,000 — concerning an endorsed drug.

advertisement

Notably, two-thirds of the doctors who endorsed a drug or device did not score highly on an index used to measure academic productivity. And half of the physicians had no publications related to the products they endorsed. In addition, 61% of the endorsements were sponsored testimonials and nearly half of the doctors failed to disclose any compensation from the manufacturers, according to the analysis in JAMA.

STAT+ Exclusive Story

STAT+

This article is exclusive to STAT+ subscribers

Unlock this article — plus in-depth analysis, newsletters, premium events, and networking platform access.

Already have an account? Log in

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe

STAT encourages you to share your voice. We welcome your commentary, criticism, and expertise on our subscriber-only platform, STAT+ Connect

To submit a correction request, please visit our Contact Us page.